Skip to main content
. 2014 Oct 2;5(10):e1434. doi: 10.1038/cddis.2014.410

Figure 5.

Figure 5

Modulation of IAP proteins and role of Apollon in the response of melanoma to the combination of target-specific inhibitors and TRAIL. (a) Modulation of IAP proteins by treatment of two melanoma cells lines (Me13 and Me41) with AZD6244 (A), BEZ235 (B) TRAIL (T) and their combinations (AB, ABT); NT: untreated. (b and c) Effect of Apollon silencing on mitochondrial depolarization (b) and cell death (c) in Me41 cells treated with the indicated agents and their combinations. (b and c) Mean values (±S.D.) for three independent experiments; statistical analysis in panels (b and c) by ANOVA followed by SNK test; ***P<0.001. **P<0.01. *P<0.05. NS, not significant